Varian Medical Systems, Inc. and Subsidiaries

United States Tax Court·Decided August 26, 2024·No. 8435-23·Published

Opinion

United States Tax Court

163 T.C. No. 4

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES, Petitioner

v.

COMMISSIONER OF INTERNAL REVENUE, Respondent

amounts treated as dividends under I.R.C. § 78, then I.R.C. § 245A(d)(1) limits the foreign tax credits to which P would otherwise be entitled.

Held: P is entitled under I.R.C. § 245A to a deduction for amounts properly treated as dividends under I.R.C. § 78 for its 2018 tax year.

Held, further, Treas. Reg. § 1.78-1 does not alter this conclusion because it cannot contravene the clear statutory text.

Held, further, I.R.C. § 245A(d)(1) disallows foreign tax credits to the extent they are attributable to amounts P properly treats as dividends under I.R.C. § 78 and deducts under I.R.C. § 245A.

Held, further, P’s Motion will be granted in part, and R’s Motion will be granted in part.

enacted by the TCJA (section 245A) actually apply? We answer both questions by following the plain text of the relevant provisions.

Congress enacted the TCJA in 2017. Among other things, the TCJA added to the Code new section 245A, which allows a domestic corporation a deduction for certain dividends received from foreign subsidiaries. Section 245A applies to “distributions made after . . . December 31, 2017.” TCJA § 14101(f), 131 Stat. at 2192.

Because the deduction under section 245A applies to dividends received by a domestic corporation from a foreign corporation, it had the potential to interact with existing section 78. As in effect before the adoption of the TCJA, that section provided that, for taxpayers who claimed foreign tax credits, a specified amount “shall be treated for purposes of this title (other than section 245) as a dividend received by such domestic corporation from the foreign corporation.”

Recognizing that section 245A might otherwise allow a taxpayer who claims foreign tax credits to deduct a dividend that section 78 would have deemed the taxpayer to receive, the TCJA amended section 78 to preclude that result. But, instead of using the same effective date that it applied to section 245A, the TCJA amended section 78 for “taxable years of foreign corporations beginning after December 31, 2017, and . . . taxable years of United States shareholders in which or with which such taxable years of foreign corporations end.” TCJA § 14301(d), 131 Stat. at 2225.

For some taxpayers—including those with foreign subsidiaries with fiscal years (that is, foreign subsidiaries whose taxable years do not run from January 1 to December 31 of each year)—this effective date mismatch created a window during which section 245A was in effect, but the amendments to section 78 were not. The question before us is whether, during that window, section 245A provided one such taxpayer, Varian Medical Systems, Inc. (Varian), a deduction for a dividend that it was deemed to receive under section 78.

Seeking partial summary judgment, the Commissioner argues that, despite the disparate effective dates, Varian cannot claim a deduction for its section 78 dividend because section 245A permits a deduction only for dividends that are actually distributed (or treated as distributed) from earnings, and, in the Commissioner’s view, section 78 dividends do not satisfy this requirement. Alternatively, the

Commissioner argues that Treasury Regulation § 1.78-1, as amended June 21, 2019, disallows the deduction.

Varian disagrees, arguing that the operative text of section 245A permits the deduction and that no other provision prohibits it. Varian also argues that Treasury Regulation § 1.78-1 is invalid because it purports to apply amended section 78 to a period starting before the effective date provided in the TCJA. It therefore seeks partial summary judgment in its favor.

Because a plain reading of the statutory text authorizes the deduction under section 245A, we will grant Varian’s Motion for Partial Summary Judgment. Relatedly, we will deny the Commissioner’s Cross- Motion for Partial Summary Judgment insofar as he asks us to conclude that Varian cannot claim a deduction under section 245A for any section 78 dividend.

The Commissioner also argues that, if Varian is entitled to the deduction, section 245A(d)(1) limits the amount of foreign tax credits Varian may claim. We agree with the Commissioner on this point and therefore will grant his Motion in part.

Background

The following facts are derived from the parties’ pleadings and Motion papers. They are stated solely for the purpose of ruling on the Motions before us and not as findings of fact in this case. See Rowen v. Commissioner, 156 T.C. 101, 103 (2021) (reviewed).

Originally founded in 1948, Varian is the parent company of a consolidated group of medical device and software manufacturers. Its principal place of business is in Palo Alto, California.

Varian operates through corporations in many different countries, at least some of which are controlled foreign corporations (CFCs) as that term is defined in section 957(a). Varian and its CFCs are fiscal year taxpayers, meaning their taxable years do not end on December 31. See I.R.C. § 441(a), (d), (e). As relevant for this case, the fiscal year of Varian and its CFCs started on September 30, 2017, and ended on September 28, 2018 (2018 Year).

Varian filed a consolidated federal income tax return for the 2018 Year. On the return, Varian elected to claim foreign tax credits for foreign taxes that it was deemed to pay under section 960 and was

therefore required to “gross up” its taxable income under section 78 by reporting a dividend of approximately $159 million. Varian also claimed a deduction of approximately $60 million under section 245A in connection with the dividend it was treated as receiving under section 78 from its first tier CFCs.

The Commissioner examined Varian’s tax return and issued Varian a Notice of Deficiency in which, among other things, he disallowed Varian’s claimed deduction under section 245A. The Commissioner also increased Varian’s section 78 dividend by nearly $1.9 million. 2 The Commissioner further determined, in the alternative, that if Varian was entitled to deduct its section 78 dividend under section 245A, then “I.R.C. § 245A(d) would disallow any foreign tax credits attributable to that amount. Accordingly, [Varian’s] foreign tax credits [would] be reduced by approximately $6,362,356.”

Varian timely petitioned our Court for a redetermination of the Commissioner’s determinations. In its Petition, Varian alleged that the disallowance of its section 245A deduction was erroneous. Varian also alleged for the first time that it is entitled to additional section 245A deductions (on top of those claimed in its return) of approximately $100 million, primarily related to the portion of its section 78 dividend arising from its lower tier CFCs.

On September 27, 2023, Varian filed the Motion for Partial Summary Judgment now before us. In its Motion, Varian asks us to determine as a matter of law that it is entitled to a deduction under section 245A for its section 78 dividend for the 2018 Year. On December 4, 2023, the Commissioner filed his own Cross-Motion for Partial Summary Judgment asking for, in effect, the opposite conclusion. Further briefing ensued, and we held a hearing on the Motions on May 17, 2024. After the U.S. Supreme Court issued its decision in Loper Bright Enterprises v. Raimondo, 144 S. Ct. 2244, 2273 (2024), overruling Chevron, U.S.A., Inc. v. Natural Resources Defense Council, Inc., 467 U.S. 837 (1984), we sought the parties’ views on the impact of the Loper Bright decision on this case, which they provided on July 29, 2024.

2 Varian does not dispute this adjustment.

Discussion

I. Summary Judgment Standard

Free access — add to your briefcase to read the full text and ask questions with AI

Varian Medical Systems, Inc. and Subsidiaries, (tax 2024).

Varian Medical Systems, Inc. and Subsidiaries (Varian Medical Systems, Inc. and Subsidiaries) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Marbury v. Madison
5 U.S. 137 (Supreme Court, 1803)
Cook v. Tait
265 U.S. 47 (Supreme Court, 1924)
Iselin v. United States
270 U.S. 245 (Supreme Court, 1926)
Crooks v. Harrelson
282 U.S. 55 (Supreme Court, 1930)
Burnet v. Chicago Portrait Co.
285 U.S. 1 (Supreme Court, 1932)
Koshland v. Helvering
298 U.S. 441 (Supreme Court, 1936)
American Chicle Co. v. United States
316 U.S. 450 (Supreme Court, 1942)
Skidmore v. Swift & Co.
323 U.S. 134 (Supreme Court, 1944)
United States v. Menasche
348 U.S. 528 (Supreme Court, 1955)
Commissioner v. Bilder
369 U.S. 499 (Supreme Court, 1962)
Commissioner v. Idaho Power Co.
418 U.S. 1 (Supreme Court, 1974)
Mobil Oil Corp. v. Higginbotham
436 U.S. 618 (Supreme Court, 1978)
Russello v. United States
464 U.S. 16 (Supreme Court, 1983)
United States v. Locke
471 U.S. 84 (Supreme Court, 1985)
United States v. Ron Pair Enterprises, Inc.
489 U.S. 235 (Supreme Court, 1989)
United States v. Goodyear Tire & Rubber Co.
493 U.S. 132 (Supreme Court, 1990)
Connecticut National Bank v. Germain
503 U.S. 249 (Supreme Court, 1992)